A pharmaceutical facility may successfully complete its initial qualification and still face compliance challenges months later. Equipment ages, processes evolve, digital systems are upgraded and production pressures grow. Each change can affect the facility's validated state.
The ongoing challenge is maintaining GMP compliance every day while manufacturing continues.
The hidden risks of everyday operations
Consider a routine equipment upgrade. What appears to be a straightforward technical improvement may require updated qualification records, recalibration activities, change control reviews or modifications to computerize systems. Without effective oversight, seemingly minor modifications can create compliance gaps that only become apparent during a regulatory inspection.
Maintaining continuous GMP readiness requires manufacturers to connect equipment performance monitoring, effective change control, robust documentation and risk-based qualification strategies.
For critical manufacturing environments, this includes regular cleanroom requalification, environmental monitoring and contamination control. For computerized systems, validation activities and data integrity controls remain equally important.
Making inspection readiness part of daily operations
Organizations that consistently perform well during inspections do not treat compliance as a periodic exercise. Instead, they embed it into routine maintenance, calibration, monitoring and operational decision-making.
A risk-based approach allows team to focus qualification and requalification efforts on the equipment and systems presenting the greatest compliance risk. It also helps identify deviations earlier, improve resource allocation and strengthen inspection preparedness.
"The real test of GMP readiness is what happens between inspections. Organizations need to ensure that systems are still performing as intended and that this can be demonstrated."
By connecting CQV, CSV, cleanroom validation, calibration and GMP compliance expertise with day-to-day operations, We help pharmaceutical manufacturers preserve the validated state, identify emerging risks and maintain inspection readiness while sustaining production performance.
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of over 100,000 dedicated professionals. With more than 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and a portfolio of trusted specialized brands, including Applied Technical Services, Brightsight, Bluesign and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN SW).
SGS Building, Street no. N 203,
Jebel Ali Free Zone, P.O. Box: 18556,
Dubai, United Arab Emirates